These salt forms are not exactly the same as the active ingredient in Ozempic and are not FDA approved for use in compounding
These risks and uncertainties include, but are not limited to, the timing and logistical considerations related to updating access to the semaglutide offerings available on our platform (branded and compounded), and the related customer response
Women carry a higher percentage of body fat than men at equivalent body weight
The benefits of treating obesity often outweigh age-related concerns
A comprehensive literature search was performed in PubMed, Web of Science, Embase, and Scopus from inception to October 2025 using the keywords tirzepatide, GLP-1/GIP receptor agonist, obstructive sleep apnea, and obesity. Priority was given to randomized controlled trials, major observational studies, and relevant mechanistic research